Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 519

1.

Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.

Damman P, Kuijt WJ, Woudstra P, Haeck JD, Koch KT, Gu YL, van Straalen JP, Fischer J, Tijssen JG, Krucoff MW, de Winter RJ.

Am Heart J. 2012 May;163(5):783-9. doi: 10.1016/j.ahj.2012.01.004.

PMID:
22607855
2.

Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Haeck JD, Verouden NJ, Kuijt WJ, Koch KT, Van Straalen JP, Fischer J, Groenink M, Bilodeau L, Tijssen JG, Krucoff MW, De Winter RJ.

Am J Cardiol. 2010 Apr 15;105(8):1065-9. doi: 10.1016/j.amjcard.2009.12.003.

PMID:
20381654
3.

Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

Seo SM, Kim S, Chang K, Min J, Kim TH, Koh YS, Park HJ, Shin WS, Lee JM, Kim PJ, Chung WS, Seung KB.

Coron Artery Dis. 2011;22(6):405-10. doi: 10.1097/MCA.0b013e3283487dac.

PMID:
21701385
4.

Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.

Crimi G, Pica S, Raineri C, Bramucci E, De Ferrari GM, Klersy C, Ferlini M, Marinoni B, Repetto A, Romeo M, Rosti V, Massa M, Raisaro A, Leonardi S, Rubartelli P, Oltrona Visconti L, Ferrario M.

JACC Cardiovasc Interv. 2013 Oct;6(10):1055-63. doi: 10.1016/j.jcin.2013.05.011.

5.

Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.

Ezekowitz JA, Armstrong PW, Granger CB, Theroux P, Stebbins A, Kim RJ, Patel MR.

Am Heart J. 2010 Aug;160(2):272-8. doi: 10.1016/j.ahj.2010.05.035.

PMID:
20691832
6.

Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.

Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik T, Ergin A, Gibson CM.

Am J Cardiol. 2012 Sep 1;110(5):621-7. doi: 10.1016/j.amjcard.2012.04.041.

PMID:
22608360
7.

Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".

Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV; Herzinfarktverbund Essen..

Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8.

PMID:
18344033
8.
9.

Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.

Garcia-Alvarez A, Sitges M, Delgado V, Ortiz J, Vidal B, Poyatos S, de Caralt TM, Heras M, Bosch X, Azqueta M, Pare C, Brugada J.

Am J Cardiol. 2009 Oct 1;104(7):878-82. doi: 10.1016/j.amjcard.2009.05.025.

PMID:
19766750
10.

Intracoronary ECG ST-segment recovery during primary percutaneous intervention for ST-segment myocardial infarction: insights from a cardiac MRI study.

Wong DT, Leung MC, Das R, Puri R, Liew GY, Teo KS, Chew DP, Meredith IT, Worthley MI, Worthley SG.

Catheter Cardiovasc Interv. 2012 Nov 1;80(5):746-53. doi: 10.1002/ccd.23455.

PMID:
22422674
11.

Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction.

Appelbaum E, Kirtane AJ, Clark A, Pride YB, Gelfand EV, Harrigan CJ, Kissinger KV, Manning WJ, Gibson CM.

J Thromb Thrombolysis. 2009 Feb;27(2):123-9. doi: 10.1007/s11239-008-0197-y.

PMID:
18246410
12.

Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry).

Antoni ML, Hoogslag GE, Boden H, Liem SS, Boersma E, Fox K, Schalij MJ, Bax JJ, Delgado V.

Am J Cardiol. 2012 Jan 15;109(2):187-94. doi: 10.1016/j.amjcard.2011.08.029.

PMID:
22244127
13.

Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.

Maeng M, Nielsen PH, Busk M, Mortensen LS, Kristensen SD, Nielsen TT, Andersen HR; DANAMI-2 Investigators..

Am J Cardiol. 2010 Jun 1;105(11):1528-34. doi: 10.1016/j.amjcard.2010.01.005.

PMID:
20494656
14.
15.

One-year clinical outcome of interventionalist- versus patient-transfer strategies for primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results from the REVERSE-STEMI study.

Zhang Q, Zhang RY, Qiu JP, Zhang JF, Wang XL, Jiang L, Liao ML, Zhang JS, Hu J, Yang ZK, Shen WF.

Circ Cardiovasc Qual Outcomes. 2011 May;4(3):355-62. doi: 10.1161/CIRCOUTCOMES.110.958785.

16.
18.

NT pro-B-type natriuretic peptide levels are related to microvascular reperfusion in patients undergoing direct percutaneous transluminal coronary angioplasty for anterior ST-segment elevation myocardial infarction.

Rossetti E, Mariani M, Poli A, Palmerini T, Finazzi S, Lotzniker M, Sangiorgi D, De Servi S.

J Cardiovasc Med (Hagerstown). 2010 May;11(5):359-64. doi: 10.2459/JCM.0b013e3283366834.

PMID:
20051875
19.

Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction.

Brodie BR, Stuckey TD, Hansen C, VerSteeg DS, Muncy DB, Moore S, Gupta N, Downey WE.

Am J Cardiol. 2005 Feb 1;95(3):343-8.

PMID:
15670542
20.

Prognostic significance of admission cardiac troponin T in patients treated successfully with direct percutaneous interventions for acute ST-segment elevation myocardial infarction.

Kurowski V, Hartmann F, Killermann DP, Giannitsis E, Wiegand UK, Frey N, Müller-Bardorff M, Richardt G, Katus HA.

Crit Care Med. 2002 Oct;30(10):2229-35.

PMID:
12394949

Supplemental Content

Support Center